Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS)
CNY 30.73
(0.33%)
CNY 30.73
(0.33%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 652.1 Million CNY | 16.61% |
| 2022 | 748.4 Million CNY | 9.77% |
| 2021 | 681.81 Million CNY | 8.79% |
| 2020 | 626.69 Million CNY | -15.72% |
| 2019 | 743.63 Million CNY | 39.24% |
| 2018 | 534.05 Million CNY | 61.29% |
| 2017 | 331.11 Million CNY | 44.73% |
| 2016 | 228.77 Million CNY | 156.53% |
| 2015 | 89.18 Million CNY | 32.23% |
| 2014 | 67.44 Million CNY | 28.72% |
| 2013 | 52.39 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 175.95 Million CNY | -24.93% |
| 2024 Q2 | 191.92 Million CNY | 9.07% |
| 2024 Q3 | 217.69 Million CNY | 11.57% |
| 2023 Q4 | 234.39 Million CNY | 33.79% |
| 2023 FY | 872.73 Million CNY | 16.61% |
| 2023 Q3 | 175.19 Million CNY | 8.62% |
| 2023 Q2 | 161.29 Million CNY | -4.77% |
| 2023 Q1 | 169.36 Million CNY | -3.25% |
| 2022 Q2 | 183.78 Million CNY | 4.11% |
| 2022 Q1 | 176.51 Million CNY | -4.21% |
| 2022 FY | 748.4 Million CNY | 9.77% |
| 2022 Q4 | 175.04 Million CNY | -17.84% |
| 2022 Q3 | 213.05 Million CNY | 15.93% |
| 2021 Q2 | 181.21 Million CNY | 16.6% |
| 2021 Q1 | 155.41 Million CNY | -7.77% |
| 2021 FY | 681.81 Million CNY | 8.79% |
| 2021 Q3 | 160.89 Million CNY | -11.21% |
| 2021 Q4 | 184.27 Million CNY | 14.53% |
| 2020 FY | 626.69 Million CNY | -15.72% |
| 2020 Q1 | -142.65 Million CNY | -161.05% |
| 2020 Q2 | -144.65 Million CNY | -1.4% |
| 2020 Q3 | 169.18 Million CNY | 216.96% |
| 2020 Q4 | 168.51 Million CNY | -0.4% |
| 2019 Q3 | 168.08 Million CNY | 203.99% |
| 2019 Q2 | -161.63 Million CNY | 10.42% |
| 2019 Q1 | -180.43 Million CNY | 0.0% |
| 2019 FY | 743.63 Million CNY | 39.24% |
| 2019 Q4 | 233.68 Million CNY | 39.03% |
| 2018 FY | 534.05 Million CNY | 61.29% |
| 2017 FY | 331.11 Million CNY | 44.73% |
| 2016 FY | 228.77 Million CNY | 156.53% |
| 2016 Q1 | 28.64 Million CNY | -3.91% |
| 2016 Q2 | 28.64 Million CNY | 0.0% |
| 2015 Q2 | 17.9 Million CNY | 0.0% |
| 2015 Q1 | 17.9 Million CNY | 0.0% |
| 2015 Q4 | 29.81 Million CNY | 0.0% |
| 2015 FY | 89.18 Million CNY | 32.23% |
| 2014 FY | 67.44 Million CNY | 28.72% |
| 2013 FY | 52.39 Million CNY | 0.0% |